SARS-CoV-2 (COVID-19) ORF9B Recombinant Protein
1232.55 €
In Stock
quantity
product details
Catalog number: 223 - 20-235
Product Category: Business & Industrial > Science & Laboratory
Gentaur
Size: 0.1 mg
20-190
SARS-CoV-2 (COVID-19) ORF9B Recombinant Protein
SARS-CoV-2 (COVID-19) ORF9B Recombinant Protein
1232.55 €
9191-002mg
SARS-CoV-2 (COVID-19) ORF9b Antibody
Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. ORF9b plays a role in the inhibition of host innate immune response by targeting the mitochondrial-associated adapter MAVS. Mechanistically, it usurps the E3 ligase ITCH to trigger the degradation of MAVS, TRAF3, and TRAF6. In addition, it causes mitochondrial elongation by triggering ubiquitination and proteasomal degradation of dynamin-like protein 1/DNM1L(3).
479.30 €
9191-01mg
SARS-CoV-2 (COVID-19) ORF9b Antibody
Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. ORF9b plays a role in the inhibition of host innate immune response by targeting the mitochondrial-associated adapter MAVS. Mechanistically, it usurps the E3 ligase ITCH to trigger the degradation of MAVS, TRAF3, and TRAF6. In addition, it causes mitochondrial elongation by triggering ubiquitination and proteasomal degradation of dynamin-like protein 1/DNM1L(3).
1031.60 €
20-250
SARS-CoV-2 (COVID-19) NSP8 Recombinant Protein
SARS-CoV-2 (COVID-19) NSP8 Recombinant Protein
1232.55 €
20-251
SARS-CoV-2 (COVID-19) NSP7 Recombinant Protein
SARS-CoV-2 (COVID-19) NSP7 Recombinant Protein
1232.55 €
20-252
SARS-CoV-2 (COVID-19) NSP5 Recombinant Protein
SARS-CoV-2 (COVID-19) NSP5 Recombinant Protein